{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T22:43:58Z","timestamp":1788389038089,"version":"build-2803163510"},"reference-count":91,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:00:00Z","timestamp":1740182400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001677","name":"INSERM","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010457","name":"CHU de Bordeaux","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010457","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.bbcan.2025.189290","type":"journal-article","created":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T06:46:29Z","timestamp":1740293189000},"page":"189290","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Alpha-1 antitrypsin deficiency and primary liver cancers"],"prefix":"10.1016","volume":"1880","author":[{"given":"Carolin Victoria","family":"Schneider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Decraecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Beaufr\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Payanc\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Coilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai Markus","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulette","family":"Bioulac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fr\u00e9d\u00e9ric","family":"Blanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Le Bail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Amintas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Bouchecareilh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbcan.2025.189290_bb0005","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1056\/NEJMra1910234","article-title":"Alpha1-antitrypsin deficiency","volume":"382","author":"Strnad","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbcan.2025.189290_bb0010","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1055\/a-2122-7674","article-title":"Pediatric and adult liver disease in Alpha-1 antitrypsin deficiency","volume":"43","author":"Ruiz","year":"2023","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.bbcan.2025.189290_bb0015","article-title":"Alpha-1 antitrypsin deficiency-mediated liver toxicity: why do some patients do poorly? What do we know so far?","volume":"7","author":"Bouchecareilh","year":"2020","journal-title":"Chronic. Obstr. Pulm. Dis."},{"key":"10.1016\/j.bbcan.2025.189290_bb0020","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.jhep.2021.11.022","article-title":"Alpha-1 antitrypsin deficiency: a re-surfacing adult liver disorder","volume":"76","author":"Fromme","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbcan.2025.189290_bb0025","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/liv.14035","article-title":"Francophone d\u2019Hepatologie Gastroenterologie et nutrition, liver disease related to alpha1-antitrypsin deficiency in French children: the DEFI-ALPHA cohort","volume":"39","author":"Ruiz","year":"2019","journal-title":"Liver Int."},{"key":"10.1016\/j.bbcan.2025.189290_bb0030","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1056\/NEJM197606102942404","article-title":"Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants","volume":"294","author":"Sveger","year":"1976","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbcan.2025.189290_bb0035","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.bbcan.2025.189290_bb0040","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1053\/j.gastro.2004.09.020","article-title":"Alcohol and hepatocellular carcinoma","volume":"127","author":"Morgan","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2025.189290_bb0045","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2018-000260","article-title":"Alcohol and hepatocellular carcinoma","volume":"6","author":"Matsushita","year":"2019","journal-title":"BMJ Open Gastroenterol."},{"key":"10.1016\/j.bbcan.2025.189290_bb0050","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.jhep.2018.08.005","article-title":"Clinical and histologic features of adults with alpha-1 antitrypsin deficiency in a non-cirrhotic cohort","volume":"69","author":"Clark","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbcan.2025.189290_bb0055","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/gutjnl-2020-323729","article-title":"Hepatobiliary phenotypes of adults with alpha-1 antitrypsin deficiency","volume":"71","author":"Fromme","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.bbcan.2025.189290_bb0060","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00535-019-01548-y","article-title":"Liver disease in adults with severe alpha-1-antitrypsin deficiency","volume":"54","author":"Tanash","year":"2019","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.bbcan.2025.189290_bb0065","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"Romeo","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbcan.2025.189290_bb0070","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/ng.3417","article-title":"A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis","volume":"47","author":"Buch","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbcan.2025.189290_bb0075","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/apt.14537","article-title":"Systematic review: the natural history of alpha-1 antitrypsin deficiency, and associated liver disease","volume":"47","author":"Townsend","year":"2018","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.bbcan.2025.189290_bb0080","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1053\/j.gastro.2019.05.013","article-title":"European Alpha1-liver study, liver fibrosis and metabolic alterations in adults with alpha-1-antitrypsin deficiency caused by the PI*ZZ mutation","volume":"157","author":"Hamesch","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2025.189290_bb0085","first-page":"934","article-title":"Cirrhosis associated with alpha-1-antitrypsin deficiency: a previously unrecognized inherited disorder","volume":"73","author":"Sharp","year":"1969","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.bbcan.2025.189290_bb0090","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/00365516709090627","article-title":"Obstructive lung disease and trypsin inhibitors in alpha-1-antitrypsin deficiency","volume":"19","author":"Ganrot","year":"1967","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.bbcan.2025.189290_bb0095","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJM197212212872502","article-title":"Liver disease in adults with alpha-1 -antitrypsin deficiency","volume":"287","author":"Berg","year":"1972","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbcan.2025.189290_bb0100","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.0954-6820.1974.tb08170.x","article-title":"Cirrhosis and malignant hepatoma in alpha 1-antitrypsin deficiency","volume":"195","author":"Eriksson","year":"1974","journal-title":"Acta Med. Scand."},{"key":"10.1016\/j.bbcan.2025.189290_bb0105","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0168-8278(05)80609-9","article-title":"Prevalence of hepatocellular carcinoma in alpha-1-antitrypsin deficiency","volume":"21","author":"Propst","year":"1994","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbcan.2025.189290_bb0110","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1651-2227.1994.tb13204.x","article-title":"Malignant liver disease in alpha 1-antitrypsin deficiency","volume":"393","author":"Poley","year":"1994","journal-title":"Acta Paediatr. Suppl."},{"key":"10.1016\/j.bbcan.2025.189290_bb0115","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1056\/NEJM198603203141202","article-title":"Risk of cirrhosis and primary liver cancer in alpha 1-antitrypsin deficiency","volume":"314","author":"Eriksson","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbcan.2025.189290_bb0120","article-title":"Cancer risk in severe alpha-1 antitrypsin deficiency: the importance of early identification","volume":"60","author":"Hiller","year":"2022","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.bbcan.2025.189290_bb0125","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/joim.20016","article-title":"Alpha-1 antitrypsin deficiency associated with increased risks of skin cancer, leukemia, and hepatic cancer: a nationwide cohort study","volume":"296","author":"Korsbaek","year":"2024","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.bbcan.2025.189290_bb0130","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/liv.12504","article-title":"Alpha-1-antitrypsin deficiency: from genoma to liver disease. PiZ mouse as model for the development of liver pathology in human","volume":"35","author":"Giovannoni","year":"2015","journal-title":"Liver Int."},{"key":"10.1016\/j.bbcan.2025.189290_bb0135","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/hep.20118","article-title":"Analyses of hepatocellular proliferation in a mouse model of alpha-1-antitrypsin deficiency","volume":"39","author":"Rudnick","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.bbcan.2025.189290_bb0140","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1872-034X.2010.00663.x","article-title":"Characteristics of hepatocellular carcinoma in a murine model of alpha-1-antitrypsin deficiency","volume":"40","author":"Marcus","year":"2010","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.bbcan.2025.189290_bb0145","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1172\/JCI113999","article-title":"Accumulation of PiZ alpha 1-antitrypsin causes liver damage in transgenic mice","volume":"83","author":"Carlson","year":"1989","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2025.189290_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/cells12121663","article-title":"Increased prevalence of Alpha-1-antitrypsin deficiency in patients with biliary tract cancer and its associated Clinicopathological features","volume":"12","author":"Cornillet","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.bbcan.2025.189290_bb0155","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1002\/1097-0142(20000615)88:12<2668::AID-CNCR4>3.0.CO;2-G","article-title":"Is heterozygous alpha-1-antitrypsin deficiency type PIZ a risk factor for primary liver carcinoma?","volume":"88","author":"Zhou","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.bbcan.2025.189290_bb0160","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s002920000410","article-title":"Liver changes in heterozygote alpha 1-antitrypsin deficiency PiZ","volume":"21","author":"Zhou","year":"2000","journal-title":"Pathologe"},{"key":"10.1016\/j.bbcan.2025.189290_bb0165","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1136\/jcp.32.4.373","article-title":"Alpha-1-antitrypsin deficiency and hepatocellular carcinoma","volume":"32","author":"Kelly","year":"1979","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.bbcan.2025.189290_bb0170","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1126\/science.3264419","article-title":"Neonatal hepatitis induced by alpha 1-antitrypsin: a transgenic mouse model","volume":"242","author":"Dycaico","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2025.189290_bb0175","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/hep.1840190218","article-title":"Hepatocarcinogenesis is the sequel to hepatitis in Z#2 alpha 1-antitrypsin transgenic mice: histopathological and DNA ploidy studies","volume":"19","author":"Geller","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.bbcan.2025.189290_bb0180","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1093\/nar\/15.4.1459","article-title":"Tissue specific expression of the human alpha-1-antitrypsin gene in transgenic mice","volume":"15","author":"Sifers","year":"1987","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbcan.2025.189290_bb0185","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1097\/00000478-199806000-00012","article-title":"Liver carcinoma in PiZ alpha-1-antitrypsin deficiency","volume":"22","author":"Zhou","year":"1998","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.bbcan.2025.189290_bb0190","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00198-2017","article-title":"Survival in individuals with severe alpha 1-antitrypsin deficiency (PiZZ) in comparison to a general population with known smoking habits","volume":"50","author":"Tanash","year":"2017","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.bbcan.2025.189290_bb0195","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s12931-024-02879-y","article-title":"Risk of lung disease in the PI*SS genotype of alpha-1 antitrypsin: an EARCO research project","volume":"25","author":"Martin","year":"2024","journal-title":"Respir. Res."},{"key":"10.1016\/j.bbcan.2025.189290_bb0200","first-page":"A1569","article-title":"PiSS Alpha-1 antitrypsin deficiency: a clinical risk variant?","volume":"207","author":"Fraughen","year":"2023","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.bbcan.2025.189290_bb0205","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.2147\/COPD.S327803","article-title":"Estimated prevalence and number of PiMZ genotypes of Alpha-1 antitrypsin in seventy-four countries worldwide","volume":"16","author":"Martinez-Gonzalez","year":"2021","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"10.1016\/j.bbcan.2025.189290_bb0210","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.2147\/COPD.S137852","article-title":"Alpha-1 antitrypsin PI*SZ genotype: estimated prevalence and number of SZ subjects worldwide","volume":"12","author":"Blanco","year":"2017","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"10.1016\/j.bbcan.2025.189290_bb0215","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1093\/hmg\/ddy090","article-title":"Heteropolymerization of alpha-1-antitrypsin mutants in cell models mimicking heterozygosity","volume":"27","author":"Laffranchi","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbcan.2025.189290_bb0220","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910560","article-title":"Alpha-1 antitrypsin and hepatocellular carcinoma in liver cirrhosis: SERPINA1 MZ or MS genotype carriage decreases the risk","volume":"22","author":"Rabekova","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2025.189290_bb0225","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.7042","article-title":"Alpha-1-antitrypsin in pathogenesis of hepatocellular carcinoma","volume":"12","author":"Topic","year":"2012","journal-title":"Hepat. Mon."},{"key":"10.1016\/j.bbcan.2025.189290_bb0230","article-title":"Hepatic decompensation is accelerated in patients with cirrhosis and alpha-1 antitrypsin pi *MZ genotype","volume":"4","author":"Chen","year":"2022","journal-title":"JHEP Rep."},{"key":"10.1016\/j.bbcan.2025.189290_bb0235","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0016-5085(87)90332-5","article-title":"Diffuse hepatocellular dysplasia and carcinoma associated with the Mmalton variant of alpha 1-antitrypsin","volume":"93","author":"Reid","year":"1987","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2025.189290_bb0240","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1111\/j.1478-3231.2009.02091.x","article-title":"Z and Mmalton-1-antitrypsin deficiency-associated hepatocellular carcinoma: a genetic study","volume":"29","author":"Francalanci","year":"2009","journal-title":"Liver Int."},{"key":"10.1016\/j.bbcan.2025.189290_bb0245","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.4254\/wjh.v7.i10.1427","article-title":"Alpha-1 antitrypsin deficiency and the risk of hepatocellular carcinoma in end-stage liver disease","volume":"7","author":"Antoury","year":"2015","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.bbcan.2025.189290_bb0250","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1053\/j.gastro.2003.09.035","article-title":"Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives","volume":"125","author":"Elmberg","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2025.189290_bb0255","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.51","article-title":"alpha1-antitrypsin deficiency","volume":"2","author":"Greene","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.bbcan.2025.189290_bb0260","first-page":"63","article-title":"alpha1-antitrypsin deficiency: a misfolded secretory protein variant with unique effects on the endoplasmic reticulum","volume":"3","author":"Perlmutter","year":"2016","journal-title":"Endoplasmic Reticulum Stress Dis."},{"key":"10.1016\/j.bbcan.2025.189290_bb0265","doi-asserted-by":"crossref","first-page":"27769","DOI":"10.1074\/jbc.M704330200","article-title":"Regulator of G signaling 16 is a marker for the distinct endoplasmic reticulum stress state associated with aggregated mutant alpha1-antitrypsin Z in the classical form of alpha1-antitrypsin deficiency","volume":"282","author":"Hidvegi","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2025.189290_bb0270","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jhep.2018.05.028","article-title":"hiPSC hepatocyte model demonstrates the role of unfolded protein response and inflammatory networks in alpha1-antitrypsin deficiency","volume":"69","author":"Segeritz","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbcan.2025.189290_bb0275","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12944-015-0069-3","article-title":"Fibrinogen production is enhanced in an in-vitro model of non-alcoholic fatty liver disease: an isolated risk factor for cardiovascular events?","volume":"14","author":"Yeung","year":"2015","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.bbcan.2025.189290_bb0280","first-page":"246","article-title":"Quantitative proteomic analysis for high-throughput screening of differential glycoproteins in hepatocellular carcinoma serum","volume":"12","author":"Gao","year":"2015","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.bbcan.2025.189290_bb0285","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/hep.1840120108","article-title":"Histopathology of alpha 1-antitrypsin liver disease in a transgenic mouse model","volume":"12","author":"Geller","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.bbcan.2025.189290_bb0290","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/hep.20815","article-title":"Alpha-1-antitrypsin deficiency: a new paradigm for hepatocellular carcinoma in genetic liver disease","volume":"42","author":"Rudnick","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.bbcan.2025.189290_bb0295","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S1470-2045(04)01414-7","article-title":"Role of imbalance between neutrophil elastase and alpha 1-antitrypsin in cancer development and progression","volume":"5","author":"Sun","year":"2004","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbcan.2025.189290_bb0300","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41590-018-0044-z","article-title":"The immunology of hepatocellular carcinoma","volume":"19","author":"Ringelhan","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbcan.2025.189290_bb0305","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s13045-021-01187-y","article-title":"Neutrophils in cancer carcinogenesis and metastasis","volume":"14","author":"Xiong","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbcan.2025.189290_bb0310","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jpha.2022.12.003","article-title":"Neutrophil elastase: from mechanisms to therapeutic potential","volume":"13","author":"Zeng","year":"2023","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.bbcan.2025.189290_bb0315","article-title":"The roles of neutrophils in the pathogenesis of liver diseases","volume":"12","author":"Tang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2025.189290_bb0320","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1219828","article-title":"Peritumoral stromal neutrophils are essential for c-met-elicited metastasis in human hepatocellular carcinoma","volume":"5","author":"He","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.bbcan.2025.189290_bb0325","doi-asserted-by":"crossref","first-page":"5798","DOI":"10.4049\/jimmunol.168.11.5798","article-title":"Generation of biologically active angiostatin kringle 1-3 by activated human neutrophils","volume":"168","author":"Scapini","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbcan.2025.189290_bb0330","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jhep.2022.05.037","article-title":"Pathogenesis of primary liver carcinomas","volume":"78","author":"Paradis","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbcan.2025.189290_bb0335","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1365-2036.2010.04534.x","article-title":"Heterozygosity for the alpha1-antitrypsin Z allele may confer genetic risk of cholangiocarcinoma","volume":"33","author":"Mihalache","year":"2011","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.bbcan.2025.189290_bb0340","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-240077","article-title":"Intrahepatic cholangiocarcinoma in a non-cirrhotic liver in a patient with homozygous ZZ alpha-1 antitrypsin deficiency","volume":"14","author":"Vuurberg","year":"2021","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.bbcan.2025.189290_bb0345","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/ajcp\/78.6.878","article-title":"Alpha-1-antitrypsin (AAT) deposits in gall bladder adenocarcinoma and liver in partial AAT deficiency (pi SZ phenotype)","volume":"78","author":"Callea","year":"1982","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.bbcan.2025.189290_bb0350","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-2559.1985.tb02973.x","article-title":"Storage of alpha-1-antitrypsin in intrahepatic bile duct cells in alpha-1-antitrypsin deficiency (pi Z phenotype)","volume":"9","author":"Callea","year":"1985","journal-title":"Histopathology"},{"key":"10.1016\/j.bbcan.2025.189290_bb0355","doi-asserted-by":"crossref","first-page":"5101","DOI":"10.1038\/s41467-018-07460-y","article-title":"Genome-wide association meta-analysis yields 20 loci associated with gallstone disease","volume":"9","author":"Ferkingstad","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2025.189290_bb0360","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/hep.27133","article-title":"BRAF V600E mutations in bile duct adenomas","volume":"61","author":"Pujals","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.bbcan.2025.189290_bb0365","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/his.13083","article-title":"BRAF V600E mutation in biliary proliferations associated with alpha(1) -antitrypsin deficiency","volume":"70","author":"Angkathunyakul","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.bbcan.2025.189290_bb0370","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3109\/00365519609090594","article-title":"Immunochemical and functional properties of biliary alpha-1-antitrypsin","volume":"56","author":"Janciauskiene","year":"1996","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.bbcan.2025.189290_bb0375","first-page":"461","article-title":"Alpha1-antitrypsin deficiency allele carriers among lung cancer patients","volume":"8","author":"Yang","year":"1999","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.bbcan.2025.189290_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2020.100914","article-title":"Alpha-1 antitrypsin deficiency and risk of lung cancer: a systematic review","volume":"14","author":"Tubio-Perez","year":"2021","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.bbcan.2025.189290_bb0385","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12885-022-09190-3","article-title":"Alpha-1 antitrypsin deficiency and risk of lung cancer in never-smokers: a multicentre case-control study","volume":"22","author":"Tubio-Perez","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbcan.2025.189290_bb0390","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000153720","article-title":"Distribution of alpha-1-antitrypsin and haptoglobin phenotypes in bladder cancer patients","volume":"37","author":"Benkmann","year":"1987","journal-title":"Hum. Hered."},{"key":"10.1016\/j.bbcan.2025.189290_bb0395","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1006\/mgme.2000.3089","article-title":"Higher risk of mismatch repair-deficient colorectal cancer in alpha(1)-antitrypsin deficiency carriers and cigarette smokers","volume":"71","author":"Yang","year":"2000","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbcan.2025.189290_bb0400","article-title":"Regarding: Alpha-1 antitrypsin deficiency associated with increased risks of skin cancer, leukemia, and hepatic cancer: a nationwide cohort study","author":"Fromme","year":"2024","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.bbcan.2025.189290_bb0405","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232213737","article-title":"Alpha-1 antitrypsin inhibits tumorigenesis and progression of colitis-associated Colon Cancer through suppression of inflammatory neutrophil-activated serine proteases and IGFBP-3 proteolysis","volume":"23","author":"Cai","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2025.189290_bb0410","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/joim.12239","article-title":"Role of alpha-1 antitrypsin in human health and disease","volume":"276","author":"de Serres","year":"2014","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.bbcan.2025.189290_bb0415","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1378\/chest.128.4.1989","article-title":"Delay in diagnosis of alpha1-antitrypsin deficiency: a continuing problem","volume":"128","author":"Stoller","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.bbcan.2025.189290_bb0420","doi-asserted-by":"crossref","first-page":"915","DOI":"10.4187\/respcare.06555","article-title":"The impact of delayed diagnosis of Alpha-1 antitrypsin deficiency: the association between diagnostic delay and worsened clinical status","volume":"64","author":"Tejwani","year":"2019","journal-title":"Respir. Care"},{"key":"10.1016\/j.bbcan.2025.189290_bb0425","doi-asserted-by":"crossref","first-page":"396","DOI":"10.34197\/ats-scholar.2023-0128ED","article-title":"Provider education in alpha 1 antitrypsin deficiency: try again, fail again, fail better","volume":"4","author":"Roche","year":"2023","journal-title":"ATS Sch."},{"key":"10.1016\/j.bbcan.2025.189290_bb0430","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12931-023-02338-0","article-title":"The impact of diagnostic delay on survival in alpha-1-antitrypsin deficiency: results from the Austrian Alpha-1 lung registry","volume":"24","author":"Meischl","year":"2023","journal-title":"Respir. Res."},{"key":"10.1016\/j.bbcan.2025.189290_bb0435","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/ng.2256","article-title":"Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma","volume":"44","author":"Guichard","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbcan.2025.189290_bb0440","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/ng.3252","article-title":"Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets","volume":"47","author":"Schulze","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbcan.2025.189290_bb0445","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMoa2205416","article-title":"Fazirsiran for liver disease associated with alpha(1)-antitrypsin deficiency","volume":"387","author":"Strnad","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbcan.2025.189290_bb0450","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.rmed.2008.01.009","article-title":"Alpha-1 antitrypsin null mutations and severity of emphysema","volume":"102","author":"Fregonese","year":"2008","journal-title":"Respir. Med."},{"key":"10.1016\/j.bbcan.2025.189290_bb0455","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.cgh.2023.08.038","article-title":"Alpha-1 Antitrypsin augmentation and the liver phenotype of adults with Alpha-1 Antitrypsin deficiency (Genotype Pi *ZZ)","volume":"22","author":"Fromme","year":"2024","journal-title":"Clin. Gastroenterol. Hepatol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X25000320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X25000320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T11:09:52Z","timestamp":1742296192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X25000320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":91,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0304419X25000320"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2025.189290","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alpha-1 antitrypsin deficiency and primary liver cancers","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2025.189290","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"189290"}}